Having “the talk” about leaving home.
Having “the talk” about leaving home. Part II: Broaching the subject.
Having “the talk” about leaving home. Part III: Making the transition.
Having “the talk” about leaving home. Part I: Signs that it’s time.
Dr. Laurie Ryan of the Division of Neuroscience at the National Institute on Aging/NIH describes how clinical trials are advancing Alzheimer’s research.
Dr. Richard J. Hodes, Director of the National Institute on Aging/NIH, discusses selected highlights from the 2013 – 2014 Alzheimer’s Disease Progress Report.
Dr. Richard J. Hodes, Director of the National Institute on Aging/NIH, welcomes viewers to the 2012-2013 Alzheimer’s Disease Progress Report: Seeking the Earliest Interventions, an annual overview of Federally-funded Alzheimer’s disease research efforts.
Recommendations from the NIH-hosted Alzheimer’s Disease-Related Dementias: Research Challenges and Opportunities meeting in May, 2013 will shape research priorities for years to come.
Dr. Neil Buckholtz, Director of the Division of Neuroscience at the National Institute on Aging/NIH, describes how biomarkers—in blood, cerebrospinal fluid and brain imaging—are advancing our ability to detect the earliest stages of Alzheimer’s, track its progression, and determine the effectiveness of promising treatments.
Dr. Thomas Obisesan describes the ADNI study which he directs at Howard University.